PSI Advisors’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

PSI Advisors’s Portfolio BTTX Stock Details BTTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-65	Closed	-$13	–	870
2023 Q4	$13	Hold	65	–	–	﹤0.01%	875
2023 Q3	$24	Hold	65	–	–	﹤0.01%	854
2023 Q2	$70	Hold	65	–	–	﹤0.01%	834
2023 Q1	$46	Hold	65	–	–	﹤0.01%	785
2022 Q4	$72	Hold	65	–	–	﹤0.01%	764
2022 Q3	$0	Hold	65	–	–	﹤0.01%	856
2022 Q2	$0	Buy	+65	New	+$109	﹤0.01%	870
2022 Q1	–	Sell	-65	Closed	–	–	816
2021 Q4	$0	Buy	+65	New	+$533	﹤0.01%	823

Other funds holding BTTX

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

APC

Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return

PSI Advisors's BTTX Position: Q1 2024 in Review

PSI Advisors sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q1 2024, closing a stake of 65 shares — an estimated $13 sold.

PSI Advisors first reported a position in BTTX in Q4 2021 and held it in 8 quarters. The position peaked at $72 in Q4 2022. 3 funds tracked by Wall St. Rank hold BTTX as of Q1 2024.

PSI Advisors reported no remaining Better Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
PSI Advisors sold 65 Better Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $13.
PSI Advisors first reported a position in Better Therapeutics, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
PSI Advisors's Better Therapeutics, Inc. Common Stock position peaked at $72 in Q4 2022.
3 funds tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q1 2024.

Based on PSI Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.